321 related articles for article (PubMed ID: 3508651)
1. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
Kimura M; Kuno-Sakai H
Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
[TBL] [Abstract][Full Text] [Related]
2. Results with a new DTP vaccine in Japan.
Kimura M; Hikino N
Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
[TBL] [Abstract][Full Text] [Related]
4. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
5. [An approach to the evaluation of the efficacy of anti-pertussis vaccination].
Barlassina C; Silvestri MG; Ariano E
Clin Ter; 1987 Aug; 122(4):245-9. PubMed ID: 2973384
[No Abstract] [Full Text] [Related]
6. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Jul; 34(27):405-14, 419-26. PubMed ID: 3925316
[No Abstract] [Full Text] [Related]
7. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
8. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
[TBL] [Abstract][Full Text] [Related]
9. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
Matter HC; Schmidt-Schläpfer G; Zimmermann H
Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
[TBL] [Abstract][Full Text] [Related]
11. Control of pertussis in the world.
Galazka A
World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
[TBL] [Abstract][Full Text] [Related]
12. Epidemic diphtheria in the Kyrgyz Republic, 1994-1998.
Glinyenko VM; Abdikarimov ST; Firsova SN; Sagamonjan EA; Kadirova R; Nuorti JP; Strebel PM
J Infect Dis; 2000 Feb; 181 Suppl 1():S98-S103. PubMed ID: 10657199
[TBL] [Abstract][Full Text] [Related]
13. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
14. [Anti-whooping cough vaccination. Contribution of a case series].
Borselli L; Giraldi P
Minerva Pediatr; 1988 Feb; 40(2):91-7. PubMed ID: 3260328
[No Abstract] [Full Text] [Related]
15. Pertussis immunization: two centuries of controversy.
Lange WR; Kreider SD
Md Med J; 1986 Sep; 35(9):753-6. PubMed ID: 3489877
[No Abstract] [Full Text] [Related]
16. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
18. Pertussis vaccination.
McAuliffe JS; Wadland WC
Am Fam Physician; 1988 Mar; 37(3):231-5. PubMed ID: 3258115
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies on efficacy and safety of acellular pertussis vaccine.
Isomura S
Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of acellular pertussis vaccine in Japan--comparison of two areas, one area where immunization started at 6 months and the other area at over 2 years of age--Regional Surveillance Committee on Tuberculosis and Infectious Diseases of Osaka.
Ohkuni H; Kitaura T; Tamai T; Takasugi Y; Sugimoto T; Fukai K
Tokai J Exp Clin Med; 1988; 13 Suppl():51-4. PubMed ID: 3273619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
